At Manningham Medical Centre, you can find all the data about Renovo Medical Trials. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab …

    https://clinicaltrials.gov/ct2/show/NCT03257033
    Locally Advanced Pancreatic Cancer. Drug: Gemcitabine Drug: nab-paclitaxel Device: RenovoCath. Phase 3. Detailed Description: All subjects will receive …

RenovoRx – Developing Innovative Solutions for …

    https://renovorx.com/
    The Phase III TIGeR-PaC clinical trial is a randomized multi-center study using RenovoRx’s innovative therapy platform, RenovoTAMP ® (RenovoRx Trans …

Renovo Stock Plummets 74% as Lead Scar Reducing …

    https://www.genengnews.com/topics/drug-discovery/renovo-stock-plummets-74-as-lead-scar-reducing-candidate-fails-in-eu-phase-iii-trial/
    Renovo’s remaining clinical pipeline is headed by Prevascar, a therapeutic formulation of human recombinant interleukin 10, which has a different mechanism of …

About TIGeR-PaC - RenovoRx

    https://renovorx.com/clinical-trials/about-tiger-pac/
    The Phase III TIGeR-PaC clinical trial is a randomized multi-center study using RenovoRx’s innovative therapy platform, RenovoTAMP ® (RenovoRx Trans-Arterial …

TIGeR-PaC Candidate Criteria - RenovoRx

    https://renovorx.com/clinical-trials/candidate-criteria/
    No prior therapy for pancreatic cancer or no more than 3 treatments with gemcitabine-Abraxane Note: Before a patient is enrolled in the study, the patient must be evaluated …

Juvista in the Non-surgical Improvement of Existing Scars

    https://clinicaltrials.gov/ct2/show/NCT00821457
    Renovo, a Biopharmaceutical company involved in the development of drugs to improve the appearance of scars and enhance wound healing, are proposing to carry …

Intra-Arterial Treatment of Pancreatic Cancer Using the …

    https://clinicaltrials.gov/ct2/show/NCT02591082
    Device: RenovoCath™ R120 Catheter. Detailed Description: This is an observational, registry study to assess patient survival and clinical outcomes of the …

A Trial to Investigate Scar Improvement Efficacy of …

    https://www.clinicaltrials.gov/ct2/show/NCT00656227
    This trial will investigate whether four doses of RN1001 (20ng, 50ng, 100ng and 200ng) are efficacious in preventing or reducing the resultant scar, as compared to …

The phase III clinical trial, TIGeR- PaC , is investigating the ...

    https://renovorx.com/wp-content/uploads/2023/01/ASCO-GI_Trials-in-Progress-Poster.pdf
    Localized dual-balloon-mediated delivery of intra-arterial gemcitabine (IAG) was demonstrated to be safe in this patient population1TIGeR-PaCis an ongoing phase III …

Clinical Studies - Renovo Equine

    https://renovoequine.com/clinical-studies/
    A Prospective Case Series Investigating The Outcomes Of Horses With Soft Tissue And Orthopedic Injuries Using RenoVō ®. A first-of-its-kind, large prospective field study …



Need more information about Renovo Medical Trials?

At Manningham Medical Centre, we collected data on more than just Renovo Medical Trials. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.